JP2015517496A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517496A5
JP2015517496A5 JP2015511575A JP2015511575A JP2015517496A5 JP 2015517496 A5 JP2015517496 A5 JP 2015517496A5 JP 2015511575 A JP2015511575 A JP 2015511575A JP 2015511575 A JP2015511575 A JP 2015511575A JP 2015517496 A5 JP2015517496 A5 JP 2015517496A5
Authority
JP
Japan
Prior art keywords
antibody
seq
set forth
domain
pnag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015511575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517496A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/039724 external-priority patent/WO2013169657A1/en
Publication of JP2015517496A publication Critical patent/JP2015517496A/ja
Publication of JP2015517496A5 publication Critical patent/JP2015517496A5/ja
Pending legal-status Critical Current

Links

JP2015511575A 2012-05-07 2013-05-06 バイオフィルム形成を防止する方法 Pending JP2015517496A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261643650P 2012-05-07 2012-05-07
US61/643,650 2012-05-07
FR1352399 2013-03-18
FR1352399 2013-03-18
PCT/US2013/039724 WO2013169657A1 (en) 2012-05-07 2013-05-06 Methods for preventing biofilm formation

Publications (2)

Publication Number Publication Date
JP2015517496A JP2015517496A (ja) 2015-06-22
JP2015517496A5 true JP2015517496A5 (https=) 2016-06-23

Family

ID=52691156

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015511575A Pending JP2015517496A (ja) 2012-05-07 2013-05-06 バイオフィルム形成を防止する方法

Country Status (2)

Country Link
US (1) US20150086601A1 (https=)
JP (1) JP2015517496A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110891596A (zh) 2017-05-04 2020-03-17 希望之城 抗体可变结构域及抗体构建体
JP2023502276A (ja) * 2019-11-22 2023-01-23 アロペックス・インコーポレイテッド Ｐｎａｇを含む微生物に対する持続的治療を提供するための方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2415358T3 (es) * 2004-04-21 2013-07-25 The Brigham And Women's Hospital, Inc. Péptidos de fijación a la poli-N-acetil glucosamina (PNAG/DPNAG) y procedimientos para el uso de los mismos

Similar Documents

Publication Publication Date Title
Ferraris et al. Antibacterial titanium surfaces for medical implants
WO2009043476A3 (en) Neuromedin s as a therapeutic agent
JP2015529225A5 (https=)
WO2009033762A3 (en) Use of endothelin-3 as a therapeutic agent
UA107115C2 (uk) Тіоацетатні похідіні піридину, композиція на їх основі та їх застосування
JP2016501892A5 (https=)
JP2016527217A5 (https=)
NZ596807A (en) Uses of immunoconjugates targeting cd138
WO2008039722A3 (en) External catheter with antiseptic agent
WO2009039983A3 (en) Use of a peptide as a therapeutic agent
WO2009033789A3 (en) Use of a peptide as a therapeutic agent
WO2009033739A3 (en) Use of a peptide as a therapeutic agent
WO2009033747A3 (en) Use of a peptide as a therapeutic agent
WO2008091925A3 (en) Treatment of aortic dissection or aneurysm
BR112013028914A2 (pt) antagonistas de receptores de integrina e seus métodos de uso
WO2009033764A3 (en) Use of a peptide as a therapeutic agent
WO2009033781A3 (en) Use of k237 as therapeutic agent
WO2009040048A3 (en) Use of the c-reactive peptide as a therapeutic agent
JP2017519768A5 (https=)
WO2009033757A3 (en) Use of mage-3 antigen (271-279) as a therapeutic agent
WO2009046829A3 (en) Casoxin d as a therapeutic agent
WO2009033723A3 (en) Use of aip2 as a therapeutic agent
WO2009039968A3 (en) Use of angiotensin iii as a therapeutic agent in the treatment of eg hbv infection
WO2011113507A3 (en) Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
JP2020502198A5 (https=)